Nuvation Bio Inc. Enters Material Definitive Agreement
Ticker: NUVB · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1811063
Sentiment: neutral
Topics: material-agreement, corporate-action
Related Tickers: NUVB
TL;DR
Nuvation Bio signed a big deal on March 3rd.
AI Summary
On March 3, 2025, Nuvation Bio Inc. entered into a material definitive agreement. The company, formerly known as Panacea Acquisition Corp. until April 30, 2020, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates a significant new contract or partnership for Nuvation Bio Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can carry inherent risks related to the terms, counterparty, and execution of the agreement.
Key Numbers
- 001-39351 — SEC File Number (Identifier for Nuvation Bio Inc.'s SEC filings)
- 85-0862255 — IRS Employer Identification No. (Tax identification number for Nuvation Bio Inc.)
Key Players & Entities
- Nuvation Bio Inc. (company) — Registrant
- Panacea Acquisition Corp. (company) — Former company name
- March 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What type of material definitive agreement did Nuvation Bio Inc. enter into?
The filing states that Nuvation Bio Inc. entered into a "Material Definitive Agreement" but does not specify the exact nature of the agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on March 3, 2025.
What was Nuvation Bio Inc.'s former company name?
Nuvation Bio Inc.'s former company name was Panacea Acquisition Corp.
In which state is Nuvation Bio Inc. incorporated?
Nuvation Bio Inc. is incorporated in Delaware.
What is Nuvation Bio Inc.'s Standard Industrial Classification (SIC) code?
Nuvation Bio Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding Nuvation Bio Inc. (NUVB).